NovoCure's Other Non-Current Liabilities rose 555.56% to $19000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $19000.0, marking a year-over-year increase of 555.56%. This contributed to the annual value of $18000.0 for FY2024, which is 0.0% changed from last year.
Per NovoCure's latest filing, its Other Non-Current Liabilities stood at $19000.0 for Q3 2025, which was up 555.56% from $18000.0 recorded in Q2 2025.
Over the past 5 years, NovoCure's Other Non-Current Liabilities peaked at $379000.0 during Q3 2021, and registered a low of $18000.0 during Q4 2023.
Over the past 5 years, NovoCure's median Other Non-Current Liabilities value was $119000.0 (recorded in 2023), while the average stood at $112368.4.
Per our database at Business Quant, NovoCure's Other Non-Current Liabilities skyrocketed by 12559.52% in 2021 and then tumbled by 8783.78% in 2023.
Over the past 5 years, NovoCure's Other Non-Current Liabilities (Quarter) stood at $166000.0 in 2021, then decreased by 10.84% to $148000.0 in 2022, then crashed by 87.84% to $18000.0 in 2023, then changed by 0.0% to $18000.0 in 2024, then increased by 5.56% to $19000.0 in 2025.
Its Other Non-Current Liabilities stands at $19000.0 for Q3 2025, versus $18000.0 for Q2 2025 and $18000.0 for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value